AquaBounty Technologies Net Income 2014-2021 | AQB

AquaBounty Technologies net income from 2014 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
AquaBounty Technologies Annual Net Income
(Millions of US $)
2020 $-16
2019 $-13
2018 $-12
2017 $-9
2016 $-8
2015 $-7
2014 $-7
2013 $-5
AquaBounty Technologies Quarterly Net Income
(Millions of US $)
2021-06-30 $-5
2021-03-31 $-4
2020-12-31 $-6
2020-09-30 $-4
2020-06-30 $-4
2020-03-31 $-3
2019-12-31 $-3
2019-09-30 $-3
2019-06-30 $-4
2019-03-31 $-3
2018-12-31 $-4
2018-09-30 $-3
2018-06-30 $-3
2018-03-31 $-2
2017-12-31 $-3
2017-09-30 $-2
2017-06-30 $-2
2017-03-31 $-2
2016-12-31 $-2
2016-09-30 $-2
2016-06-30 $-2
2016-03-31 $-2
2015-12-31
2015-09-30 $-2
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.286B $0.000B
AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43